Stroke · 2014 · 103 citations · 5 references
MedicinePharmacologyPharmacotherapyCerebrovascular SurgeryClinical PharmacologyHemostasisAnticoagulant TherapyAnticoagulation TherapyAntithrombotic TherapyCerebrovascular DiseaseStrokeThrombosisBleedingCerebral Venous SinusesClinical Severity ClassificationClinical Severity ScoringTherapeutic AnticoagulationVenous RecanalizationVitamin K Antagonist TherapyVitamin K Antagonists
BACKGROUND AND PURPOSE: Thrombosis of cerebral veins and sinus (cerebral venous thrombosis) is a rare stroke pathogenesis. Pharmaceutical treatment is restricted to heparin and oral anticoagulation with vitamin K antagonists (VKAs). METHODS: Between January 2012 and December 2013, we recorded data from our patients with cerebral venous thrombosis. The modified Rankin scale was used to assess clinical severity; excellent outcome was defined as modified Rankin scale 0 to 1. Recanalization was assessed on follow-up MR angiography. Patients were then divided into 2 treatment groups: phenprocoumon (VKA) and a novel factor Xa inhibitor. Clinical and radiological baseline data, outcome, recanalization status, and complications were retrospectively compared. RESULTS: Sixteen patients were included, and 7 were treated with rivaroxaban. Overall outcome was excellent in 93.8%, and all patients showed at least partial recanalization. No statistical significant differences were found between the groups, except the use of heparin before start of oral anticoagulation (P=0.03). One patient in the VKA and 2 patients in the factor Xa inhibitor group had minor bleeding (P=0.55) within the median (range) follow-up of 8 months (5-26). CONCLUSIONS: Factor Xa inhibitor showed a similar clinical benefit as VKA in the treatment of cerebral venous thrombosis. Further systematic prospective evaluation is warranted.
5
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
New England Journal of Medicine · 2010 · 3.2K citations · Full text
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
José M. Ferro, Patrícia Canhão, J. Stam et al. · Stroke · 2004 · 2.3K citations
Medicine, Neurosurgery, Surgery +15
Influence of Recanalization on Outcome in Dural Sinus Thrombosis
Erwin Stolz, S Trittmacher, Anousha Rahimi et al. · Stroke · 2004 · 120 citations
Medicine, Neurology, Neurosurgery +16